• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌

Lung cancer.

作者信息

Travis W D, Travis L B, Devesa S S

机构信息

Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000.

出版信息

Cancer. 1995 Jan 1;75(1 Suppl):191-202. doi: 10.1002/1097-0142(19950101)75:1+<191::aid-cncr2820751307>3.0.co;2-y.

DOI:10.1002/1097-0142(19950101)75:1+<191::aid-cncr2820751307>3.0.co;2-y
PMID:8000996
Abstract

BACKGROUND

Lung cancer is the most common cause of cancer death in the United States, and its incidence has been rising for at least 50 years. Shifts in histologic type and differences in sex and race distribution have accompanied the increased incidence of lung malignancies.

METHODS

Population-based data regarding lung cancer reported to the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program for the 15-year period 1973-1987 were analyzed.

RESULTS

Results indicate that from 1973-1977 to 1983-1987, the age-adjusted rates of lung cancer increased by 30%, with the gain markedly greater in women (70%) than in men (17%). The largest percentage increases in age-adjusted rates were observed for small cell carcinoma and adenocarcinoma (approximately 60% each), with a more modest change for squamous cell carcinoma (+ 14%). For squamous cell carcinoma, the age-adjusted rates increased substantially for black (65%) and white (70%) women and only slightly for black men (10%), whereas it decreased slightly in recent years for white men.

CONCLUSIONS

In recent years, adenocarcinoma has replaced squamous cell carcinoma as the most frequent histologic subtype for all sexes and races combined. These shifts in histologic types by sex and race may be related to differences in exposure to tobacco products, dietary factors, environmental or occupational carcinogens, and host characteristics. Increased use of transbronchial and needle biopsy may have also influenced these trends to some extent. Over the study period, 5-year relative survival rate did not change appreciably for lung cancer, suggesting that therapeutic advances have had little effect.

摘要

背景

肺癌是美国癌症死亡的最常见原因,其发病率至少在50年里一直在上升。肺癌发病率的增加伴随着组织学类型的变化以及性别和种族分布的差异。

方法

分析了1973年至1987年这15年间向美国国家癌症研究所的监测、流行病学和最终结果(SEER)计划报告的基于人群的肺癌数据。

结果

结果表明,从1973 - 1977年到1983 - 1987年,年龄调整后的肺癌发病率增加了30%,女性的增幅(70%)明显大于男性(17%)。年龄调整率增幅最大的是小细胞癌和腺癌(各约60%),鳞状细胞癌的变化较小(+14%)。对于鳞状细胞癌,黑人(65%)和白人(70%)女性的年龄调整率大幅上升,黑人男性仅略有上升(10%),而近年来白人男性的该比率略有下降。

结论

近年来,腺癌已取代鳞状细胞癌,成为所有性别和种族综合起来最常见的组织学亚型。按性别和种族划分的这些组织学类型变化可能与接触烟草制品、饮食因素、环境或职业致癌物以及宿主特征的差异有关。经支气管和针吸活检的使用增加在一定程度上也可能影响了这些趋势。在研究期间,肺癌的5年相对生存率没有明显变化,这表明治疗进展的效果甚微。

相似文献

1
Lung cancer.肺癌
Cancer. 1995 Jan 1;75(1 Suppl):191-202. doi: 10.1002/1097-0142(19950101)75:1+<191::aid-cncr2820751307>3.0.co;2-y.
2
Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009.2004 - 2009年美国肺癌发病率及按组织学类型划分的趋势模式
Lung Cancer. 2014 Oct;86(1):22-8. doi: 10.1016/j.lungcan.2014.08.001. Epub 2014 Aug 12.
3
United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females.美国肺癌发病率趋势:男性中大多数组织学类型的发病率呈下降趋势,女性则呈上升趋势。
Cancer. 1996 Jun 15;77(12):2464-70. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2464::AID-CNCR8>3.0.CO;2-M.
4
Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989.1960 - 1989年康涅狄格州肺癌组织学类型发病率的时间趋势及年龄 - 时期 - 队列效应
Cancer. 1994 Sep 1;74(5):1556-67. doi: 10.1002/1097-0142(19940901)74:5<1556::aid-cncr2820740511>3.0.co;2-0.
5
Leukemias, myeloma, and other lymphoreticular neoplasms.白血病、骨髓瘤及其他淋巴网状系统肿瘤。
Cancer. 1995 Jan 1;75(1 Suppl):381-94. doi: 10.1002/1097-0142(19950101)75:1+<381::aid-cncr2820751320>3.0.co;2-b.
6
Breast cancer.乳腺癌
Cancer. 1995 Jan 1;75(1 Suppl):257-69. doi: 10.1002/1097-0142(19950101)75:1+<257::aid-cncr2820751311>3.0.co;2-y.
7
A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA.日本大阪癌症登记处与美国监测、流行病学和最终结果计划中肺癌组织学类型发病率趋势的比较。
Jpn J Clin Oncol. 2003 Feb;33(2):98-104. doi: 10.1093/jjco/hyg019.
8
Assessing changes in the impact of cancer on population survival without considering cause of death.在不考虑死亡原因的情况下评估癌症对人群生存影响的变化。
J Natl Cancer Inst. 1997 Jan 1;89(1):58-65. doi: 10.1093/jnci/89.1.58.
9
Trends in esophageal cancer incidence by histology, United States, 1998-2003.1998 - 2003年美国按组织学分类的食管癌发病率趋势
Int J Cancer. 2008 Sep 15;123(6):1422-8. doi: 10.1002/ijc.23691.
10
Brain, other central nervous system, and eye cancer.脑癌、其他中枢神经系统癌症和眼癌。
Cancer. 1995 Jan 1;75(1 Suppl):330-7. doi: 10.1002/1097-0142(19950101)75:1+<330::aid-cncr2820751315>3.0.co;2-5.

引用本文的文献

1
Response of EGFR-mutated pulmonary pleomorphic carcinoma to pembrolizumab.表皮生长因子受体(EGFR)突变型肺多形性癌对帕博利珠单抗的反应
Respir Med Case Rep. 2025 May 14;56:102234. doi: 10.1016/j.rmcr.2025.102234. eCollection 2025.
2
Neighborhood-Regularized Matrix Factorization for lncRNA-Disease Association Identification.用于长链非编码RNA-疾病关联识别的邻域正则化矩阵分解
Int J Mol Sci. 2025 Apr 30;26(9):4283. doi: 10.3390/ijms26094283.
3
DeepWalk-Based Graph Embeddings for miRNA-Disease Association Prediction Using Deep Neural Network.
基于深度游走的图嵌入用于使用深度神经网络进行miRNA-疾病关联预测
Biomedicines. 2025 Feb 20;13(3):536. doi: 10.3390/biomedicines13030536.
4
Graph Convolutional Network with Neural Collaborative Filtering for Predicting miRNA-Disease Association.基于神经协同过滤的图卷积网络用于预测miRNA-疾病关联
Biomedicines. 2025 Jan 8;13(1):136. doi: 10.3390/biomedicines13010136.
5
Surgically resected sarcomatoid carcinoma of the lung: a nationwide retrospective study in 2010.手术切除的肺肉瘤样癌:2010 年全国回顾性研究。
BMC Cancer. 2024 Aug 2;24(1):938. doi: 10.1186/s12885-024-12728-2.
6
Disease prognosis and therapeutic strategies in patients with advanced non-small cell lung cancer (NSCLC): a 6-year epidemiological study between 2015-2021.晚期非小细胞肺癌(NSCLC)患者的疾病预后及治疗策略:一项2015年至2021年的6年流行病学研究
Transl Cancer Res. 2024 Feb 29;13(2):762-770. doi: 10.21037/tcr-23-1816. Epub 2024 Feb 23.
7
[Evolution of the incidence and survival of bronchogenic carcinoma in the province of Castellón (Spain) from 2004 to 2017.].[2004年至2017年西班牙卡斯特利翁省支气管源性癌的发病率及生存率演变。]
Rev Esp Salud Publica. 2023 Jun 14;97:e202306050.
8
Prognostic Significance of Iron Metabolism Related Genes in Human Lung Adenocarcinoma.铁代谢相关基因在人肺腺癌中的预后意义
Cancer Manag Res. 2023 Feb 22;15:203-216. doi: 10.2147/CMAR.S398982. eCollection 2023.
9
Lung cancer immunotherapy: progress, pitfalls, and promises.肺癌免疫疗法:进展、陷阱和前景。
Mol Cancer. 2023 Feb 21;22(1):40. doi: 10.1186/s12943-023-01740-y.
10
An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870).一项针对接受二线纳武利尤单抗单药治疗的亚洲晚期非小细胞肺癌患者的开放标签安全性研究(CheckMate 870)。
Ther Adv Med Oncol. 2022 Nov 19;14:17588359221138380. doi: 10.1177/17588359221138380. eCollection 2022.